Global Heparin Market size is expected to reach US$ 7.8 billion by 2026 and is projected to expand at a CAGR of 1.6% from forecast period 2019 to 2026.
Increasing number of accidents and surgeries is expected to be a key driver for the growth. Increasing incidence of venous thromboembolism and cardiovascular disorders is expected to fuel the market growth over the forecast period.
According to the data published in the Centers for Disease Control and Prevention (CDC) in 2018, around 900,000 people in U.S. are affected by deep vein thrombosis and pulmonary embolism each year. This factor is projected to propel the regional demand in the forthcoming years.
Some biopharmaceutical companies are financing resources for the development of new drugs. Organizations such as the CDC and the National Institutes of Health (NIH) are undertaking initiatives for increasing awareness levels through programs that aim preventing thrombosis-associated complications in initial stages.
High demand for anticoagulants is anticipated to boost the overall heparin market. Furthermore, high healthcare expenditures and patient awareness levels are some of the key factors anticipated to accelerate the market over the forecast period.
The main objective of this report is to define, describe, and forecast the global heparin market by types, application, industry verticals, and regions. The report provides detailed information about the major factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the market. The report aims to strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global market. The report also attempts to forecast the market size of the 5 main regions: North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It strategically profiles the key market players and comprehensively analyzes their core competencies. It also tracks and analyzes the competitive developments, such as joint ventures, mergers and acquisitions, new developments, and Research and Development (R&D) activities, in heparin Market.
The main objective of this report is to aid the user in understanding the market as a whole, its definitions, segmentation, market potential, influential trends, and the barriers that it is facing. Meticulous research and analysis were an important part of the report preparation. Those reading the report will be able to get a detailed understanding about the market. Industry experts have verified and checked the data and information that have been taken from credible sources like websites, annual reports of companies, journals, and other resources. In order give the facts and data a pictorial form, diagrams, graphs, pie charts, and other representations have been used. That augments the visual appeal of the report and makes understanding it much easier.
Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global heparin market report on the basis of type, route of administration, application, end use, and region:
Type Outlook (Revenue, USD Million, 2014 - 2026)
Low Molecular Weight Heparin
Ultra-low Molecular Weight Heparin
Unfractionated Heparin
Route of Administration Outlook (Revenue, USD Million, 2014 - 2026)
Intravenous
Subcutaneous
Application Outlook (Revenue, USD Million, 2014 - 2026)
Venous Thromboembolism
Atrial Fibrillation
Renal Impairment
Coronary Artery Disease
Others
End Use Outlook (Revenue, USD Million, 2014 - 2026)
Outpatient
Inpatient
Regional Outlook (Revenue, USD Million, 2014 - 2026)
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Asia Pacific
Japan
China
India
South Korea
Australia
Singapore
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Heparin Market, By Type
7.1. Heparin Market, By Type, 2020-2028
7.1.1. Low Molecular Weight Heparin
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Ultra-low Molecular Weight Heparin
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Unfractionated Heparin
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Heparin Market, By Application
8.1. Heparin Market, by Application, 2020-2028
8.1.1. Venous Thromboembolism
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Atrial Fibrillation
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Renal Impairment
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Coronary Artery Disease
8.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Heparin Market, By End User
9.1. Heparin Market, by End User, 2020-2028
9.1.1. Outpatient
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. Inpatient
9.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Heparin Market, By Route of Administration
10.1. Heparin Market, By Route of Administration, 2020-2028
10.1.1. Intravenous
10.1.1.1. Market Revenue and Forecast (2016-2028)
10.1.2. Subcutaneous
10.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 11. Global Heparin Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Type (2016-2028)
11.1.2. Market Revenue and Forecast, by Application (2016-2028)
11.1.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.1.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.1.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.1.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.1.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.7.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.7.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Type (2016-2028)
11.2.8.2. Market Revenue and Forecast, by Application (2016-2028)
11.2.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.8.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.7.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.7.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Type (2016-2028)
11.3.8.2. Market Revenue and Forecast, by Application (2016-2028)
11.3.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.8.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.7.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.7.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Type (2016-2028)
11.4.8.2. Market Revenue and Forecast, by Application (2016-2028)
11.4.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.8.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Type (2016-2028)
11.5.5.2. Market Revenue and Forecast, by Application (2016-2028)
11.5.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.5.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Type (2016-2028)
11.5.6.2. Market Revenue and Forecast, by Application (2016-2028)
11.5.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.6.4. Market Revenue and Forecast, By Route of Administration (2016-2028)
Chapter 12. Company Profiles
12.1. GlaxoSmithKline plc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Pfizer, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Baxter
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Leo Pharma A/S
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sanofi
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Dr. Reddy’s Laboratories Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Aspen Holdings
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. B. Braun Medical Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Fresenius SE & Co. KGaA
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Teva Pharmaceutical Industries Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers